REFERENCES
- Katzenstein H M, Bowman L C, Brodeur G M, et al. Prognostic significance of age, MYCN oncogene amplification, tumor cell ploidy, and histology in 110 infants with stage D(S) neuroblastoma: The Pediatric Oncology Group experience—a Pediatric Oncology Group study. J Clin Oncol. 1998; 16: 2007–2017
- Blatt J, Deutsch M, Wollman M R. Results of therapy in stage IV-S neuroblastoma with massive hepatomegaly. Int J Radiat Oncol Biol Physiol. 1987; 13: 1467–1471
- Hsu L L, Evans A E, D’Angio G J. Hepatomegaly in neuroblastoma stage 4s: criteria for treatment of the vulnerable neonate. Med Pediatr Oncol. 1996; 27: 521–528
- Stephenson S R, Cook B A, Mease A D, et al. The prognosticsignificance of age and pattern of metastases in stage IV-S neuroblastoma. Cancer 1986; 58: 372–375
- Peschel R E, Chen M, Seashore J. The treatmenrt of massive hepatomegaly in stage IV-S neuroblastoma. Int J Radiat Oncol Biol Physiol. 1981; 7: 549–553
- Schnaufer L, Koop C E. Silastic abdominal patch for temporary hepatomegaly in stage IV-S neuroblastoma. J Pediatr Surg. 1975; 10: 73–75
- Lee E W, Applebaum H. Abdominal expansion as a bridging technique in stage IV-S neuroblastoma with massive hepatomegaly. J Pediatr Surg. 1994; 29: 1470–1471
- McGahren E D, Rodgers B M, Waldron P E. Successful management of stage 4S neuroblastoma and severe hepatomegaly using absorbable mesh in an infant. J Pediatr Surg. 1998; 33: 1554–1557
- Boztug K, Kiely E, Roebuck D J, et al. Successful treatment of MYCN amplified, progressive stage 4S neuroblastoma in a neonate with hepatic artery embolization in addition to multimodality treatment. Pediatr Blood Cancer 2006; 46: 253–257
- Van Noesel M M, Hählen K, Hakvoort-Cammel F GAJ, et al. Neuroblastoma 4S. Cancer 1997; 80: 834–843